Moderna May Have The Best Shot At A Vaccine For Stomach Flu [Forbes]
HilleVax, Inc. (HLVX)
Company Research
Source: Forbes
There's no approved norovirus vaccine yet, but several companies are working on it. getty E very year , somewhere between 19 and 21 million Americans come down with gastroenteritis (aka “stomach flu”), most often caused by a group of pathogens called noroviruses. These infections lead to hundreds of thousands of ER visits and hospitalizations, as well as around 900 deaths, every year. This winter, norovirus infections are particularly bad in the U.S., according to the CDC, which is of the last decade. There are two possible reasons for the current surge, Daniel Kuritzkes, chief of infectious diseases at Harvard Medical School told Forbes. The first is that strains of circulating viruses change each year, which reduces immune protections s
Read more
Impact Snapshot
Event Time:
HLVX
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
HLVX alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
HLVX alerts
High impacting HilleVax, Inc. news events
Weekly update
A roundup of the hottest topics
HLVX
News
- Frazier Life Sciences Appoints Aditya Kohli to Partner [Yahoo! Finance]Yahoo! Finance
- Frazier Life Sciences Appoints Aditya Kohli to PartnerBusiness Wire
- Frazier Life Sciences Welcomes Chris Aakre as Principal of Company Creation [Yahoo! Finance]Yahoo! Finance
- HilleVax, Inc. (NASDAQ: HLVX) had its "neutral" rating re-affirmed by analysts at HC Wainwright. They now have a $2.00 price target on the stock.MarketBeat
- HilleVax Reports Full Year 2024 Financial Results and Highlights Recent Company ProgressGlobeNewswire
HLVX
Earnings
- 3/28/25 - Miss
HLVX
Analyst Actions
- 3/31/25 - HC Wainwright
HLVX
Sec Filings
- 3/28/25 - Form 10-K
- 3/28/25 - Form 8-K
- 2/12/25 - Form 4
- HLVX's page on the SEC website